Source: Wall Street Journal Author: Ron Johnson

video

Google’s YouTube has ratcheted up censorship to a new level by removing two videos from a U.S. Senate committee. They were from a Dec. 8 Committee on Homeland Security and Governmental Affairs hearing on early treatment of Covid-19. One was a 30-minute summary; the other was the opening statement of critical-care specialist Pierre Kory.

Dr. Kory is part of a world-renowned group of physicians who developed a groundbreaking use of corticosteroids to treat hospitalized Covid patients. His testimony at a May Senate hearing helped doctors rethink treatment protocols and saved lives.

At the December hearing, he presented evidence regarding the use of ivermectin, a cheap and widely available drug that treats tropical diseases caused by parasites, for prevention and early treatment of Covid-19. He described a just-published study from Argentina in which about 800 health-care workers received ivermectin and 400 didn’t. Not one of the 800 contracted Covid-19; 58% of the 400 did.

Dr. Kory asked the National Institutes of Health to review his group’s manuscript outlining dozens of successful trials and to consider updating its Aug. 27 guidance in which it recommended “against the use of ivermectin for the treatment of Covid-19, except in a clinical trial.” On Dec. 10, Sen. Rand Paul and I sent a letter to the NIH requesting that it review Dr. Kory’s evidence.

On Jan. 14, NIH changed its guidance to neutral by acknowledging the successful trials but determined “that currently there are insufficient data to recommend either for or against the use of ivermectin for the treatment of Covid-19.” On Jan. 22 I sent an oversight letter asking what actions the NIH had taken to explore the use of repurposed drugs for treating Covid-19.

For the full story, click here: Wall Street Journal



Related:
Hydroxychloroquine and Ivermectin: The medical establishment’s war on COVID therapeutics

HCQ and Ivermectin included in multifaceted highly targeted sequential multidrug treatment of early ambulatory high-risk COVID-19

Facebook Oversight Board admits Facebook was wrong to censor information about Hydroxychloroquine

Not Using Ivermectin, One Year In, Is Unethical And Immoral

COVID-19: A realistic approach to community management – HCQ & IVM in concert with vaccination

Share on facebook
Share on twitter
Share on whatsapp
On Trend

Latest Stories

American Hero: Ralph C. Lorigo Fights for Client Rights Including Access to Ivermectin for COVID-19 Patients At Risk

Lorigo shared with TrialSite that once doctors learn of all of the studies around the world, and start doing their own homework, they become more open-minded, factoring in the risk-reward analysis. Especially if elderly high risk patients present advanced COVID-19, Lorigo has personally seen the drug potentially contribute to saving the lives of clients. Interestingly, the attorney reports that it would appear that hospital administrations are the most recalcitrant to the idea, even if the patients and the ICU doctor are in support.

Read More »

The Chloroquine Wars Part XIV – How to Rig Research: Surgisphere Part I

It was in these very moments in late May when public health officials lost all credibility—a credibility that cannot be restored without major changes taking place. Despite most evidence pointing to a likelihood of HCQ efficacy, they made their call on the back of data supposedly tucked away in a database that nobody had verified, declared it definitive, then swiftly pushed for policy changes around the world.

Read More »